• Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GeneReach Biotechnology Corp

+ Add to Watchlist

4171:TT

55.40 TWD 3.60 6.95%

As of 01:31:56 ET on 12/22/2014.

Snapshot for GeneReach Biotechnology Corp (4171)

Open: 53.00 Day's Range: 51.00 - 55.40 Volume: 330,240
Previous Close: 51.80 52wk Range: 34.30 - 76.00 1-Yr Rtn: +43.90%

Stock Chart for 4171

No chart data available.
  • 4171:TT 55.40
  • 1D
  • 1M
  • 1Y
51.80
Interactive 4171 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4171

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TWOTCI -
Earnings Per Share (ttm) -1.9100
Est. EPS -
Est. PEG Ratio -
Market Cap (M TWD) 1,902.44
Shares Outstanding (M) 34.34
30 Day Average Volume 388,535
Price/Book (mrq) 7.4925
Price/Sale (ttm) 17.5137
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4171

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4171

GeneReach Biotechnology Corp. operates as a molecular diagnostic company in Taiwan. The company engages in the development, manufacture, and marketing of nucleic acid extraction kits and instruments. Its products are used in aquaculture, live stock, agriculture, and companion animal industries. The company was founded in 2004 and is based in Taichung City, Taiwan.

Liu Cheng-ChungChairman/CEOChang Hsiao-FenChief Executive Officer
Su ChengExecutive DirectorChung Te-YuVice President:Sales
More Company Profile & Key Executives for 4171

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil